Resultados de la búsqueda 331-340 of 1773 for Off-label
Mayo Clinic Minute: New rule for 'healthy' food labels Jan. 20, 2025, 03 ... Fight off the flu with immune-boosting nutrients Dec. 14, 2023, 02:30 p.m. ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...
... out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release. International Penile Advanced ...
... out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release. Long-Term Follow-up Protocol ...
The purpose of this study is to establish a tissue bank to collect patient tissue for genomic analysis, allowing identification of genomic signatures that ...
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?